HSPA2 and early-onset autosomal dominant Alzheimer disease: HSPA2 elevated Aβ40 and Aβ42 levels and phosphorylated-tau in two cell lines with HSPA2 overexpression and was nominated HSPA2 as a specific key regulator of late-onset Alzheimer's disease [24].